Epidural spread of surgical site infection from spinal cord stimulation trial. uri icon

Overview

abstract

  • We present a case of deep surgical site infection (SSI) at a spinal cord stimulator (SCS) trial implantation site, resulting from an allergic reaction to an unknown agent. A 38-year-old female with complex regional pain syndrome began an SCS trial, noting 100% pain relief for 5 days. Fluid drainage from the surgical site was reported on POD6 and trial leads were removed the following day. The patient was hospitalized with sepsis. Blood cultures revealed Staphylococcus aureus. MRIs showed skin breakdown and cellulitis of the paraspinal musculature extending into the epidural space. The patient was maintained with antibiotics and rigorous wound care for 9 days and the surgical site infection resolved. The patient proceeded to SCS implantation, and reported good pain relief with the implanted device.

publication date

  • July 8, 2024

Research

keywords

  • Spinal Cord Stimulation
  • Surgical Wound Infection

Identity

PubMed Central ID

  • PMC11340739

Scopus Document Identifier

  • 85197730687

Digital Object Identifier (DOI)

  • 10.1080/17581869.2024.2373044

PubMed ID

  • 38973311

Additional Document Info

volume

  • 14

issue

  • 5-6